Pharmacokinetics and metabolism in mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a new oral c-seco-taxane derivative with antiangiogenic property effective on paclitaxel-resistant tumors - Frapolli, R; Marangon, E; Zaffaroni, M; Colombo, T; Falcioni, C; Bagnati, R; Simone, M; DʼIncalci, M; Manzotti, C; Fontana, G; Morazzoni, P; Zucchetti, M (Drug Metab Dispos, 2006)